1. Home
  2. HRMY vs AMRC Comparison

HRMY vs AMRC Comparison

Compare HRMY & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.06

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Ameresco Inc.

AMRC

Ameresco Inc.

HOLD

Current Price

$31.16

Market Cap

1.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
AMRC
Founded
2017
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Engineering & Construction
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
HRMY
AMRC
Price
$37.06
$31.16
Analyst Decision
Strong Buy
Buy
Analyst Count
8
9
Target Price
$49.75
$33.22
AVG Volume (30 Days)
612.6K
531.2K
Earning Date
02-24-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
50.44
18.87
EPS
3.17
1.19
Revenue
$825,944,000.00
$1,883,767,000.00
Revenue This Year
$23.34
$9.83
Revenue Next Year
$16.28
$9.83
P/E Ratio
$11.49
$22.38
Revenue Growth
21.13
12.22
52 Week Low
$25.52
$8.49
52 Week High
$40.87
$44.93

Technical Indicators

Market Signals
Indicator
HRMY
AMRC
Relative Strength Index (RSI) 48.18 40.58
Support Level $36.27 $26.29
Resistance Level $38.04 $32.76
Average True Range (ATR) 1.18 1.93
MACD -0.03 -0.47
Stochastic Oscillator 50.14 26.23

Price Performance

Historical Comparison
HRMY
AMRC

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About AMRC Ameresco Inc.

Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of its revenue from the U.S. Regions segment.

Share on Social Networks: